Double maintains 1 strategies that include ACLX - Arcellx, Inc.
Current Value
$65.551 Year Return
Current Value
$65.551 Year Return
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
TEF | 0.03% | $26.30B | +6.15% | 6.71% |
CCEC | 0.05% | $1.12B | +11.47% | 3.12% |
DUK | -0.05% | $94.77B | +26.96% | 3.42% |
PDD | 0.07% | $164.36B | -0.68% | 0.00% |
NOC | -0.10% | $74.12B | +8.63% | 1.60% |
CMS | 0.16% | $22.47B | +25.23% | 2.79% |
DXCM | 0.17% | $26.69B | -50.49% | 0.00% |
CHD | 0.24% | $27.09B | +4.83% | 1.03% |
PPC | 0.26% | $12.93B | +57.95% | 0.00% |
VZ | -0.27% | $190.95B | +7.28% | 5.89% |
D | 0.30% | $47.77B | +14.06% | 4.77% |
TME | 0.32% | $10.08B | +29.59% | 0.95% |
RILY | 0.49% | $118.02M | -82.78% | 12.80% |
WEC | 0.63% | $34.42B | +33.62% | 3.12% |
SUZ | 0.63% | $11.51B | -25.17% | 0.00% |
NTES | 0.83% | $64.06B | +4.27% | 2.45% |
ETR | -0.95% | $36.83B | +63.24% | 4.75% |
VSTA | 0.96% | $363.18M | +12.97% | 0.00% |
PM | -1.07% | $246.80B | +73.59% | 3.38% |
CPSH | -1.11% | $23.10M | -10.67% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XBI | 60.76% | $5.33B | 0.35% |
CPRJ | 60.61% | $48.46M | 0.69% |
RSPA | 59.06% | $290.25M | 0% |
IBB | 57.02% | $5.92B | 0.45% |
IWC | 55.27% | $810.14M | 0.6% |
KAPR | 54.41% | $185.00M | 0.79% |
IWO | 54.36% | $10.88B | 0.24% |
VTWO | 54.28% | $10.91B | 0.07% |
IWM | 54.28% | $64.21B | 0.19% |
SCHA | 53.39% | $15.95B | 0.04% |
KJUL | 53.21% | $155.38M | 0.79% |
PTH | 53.15% | $110.42M | 0.6% |
PBE | 52.76% | $233.11M | 0.58% |
NUSC | 52.59% | $1.11B | 0.31% |
KJAN | 52.44% | $318.03M | 0.79% |
ESML | 52.34% | $1.76B | 0.17% |
ISCG | 52.32% | $654.50M | 0.06% |
GNOM | 52.25% | $53.29M | 0.5% |
SMMD | 52.22% | $1.29B | 0.15% |
GSSC | 52.19% | $512.57M | 0.2% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BNO | -0.05% | $95.40M | 1% |
PDBC | -0.05% | $4.82B | 0.59% |
COMT | -0.06% | $674.22M | 0.48% |
TBLL | 0.12% | $2.07B | 0.08% |
GSG | -0.21% | $1.04B | 0.75% |
DBO | 0.23% | $197.54M | 0.77% |
BSMW | -0.30% | $100.61M | 0.18% |
FLMI | 0.30% | $608.25M | 0.3% |
SGOV | -0.30% | $39.39B | 0.09% |
KMLM | 0.30% | $222.40M | 0.9% |
TAXF | -0.34% | $515.52M | 0.29% |
XBIL | 0.47% | $708.45M | 0.15% |
SUB | 0.51% | $8.75B | 0.07% |
DBC | 0.54% | $1.32B | 0.87% |
DFNM | 0.65% | $1.50B | 0.17% |
IBTG | -0.73% | $1.82B | 0.07% |
USL | 0.75% | $46.60M | 0.85% |
FXY | -0.98% | $546.19M | 0.4% |
BIL | 1.10% | $41.08B | 0.1356% |
GXC | 1.12% | $474.99M | 0.59% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
VIXY | -42.96% | $195.31M | 0.85% |
BTAL | -35.17% | $404.97M | 1.43% |
TAIL | -32.45% | $86.92M | 0.59% |
CTA | -13.56% | $963.19M | 0.76% |
WEAT | -10.87% | $113.78M | 0.28% |
USDU | -10.52% | $213.46M | 0.5% |
XHLF | -10.40% | $1.06B | 0.03% |
TPMN | -8.72% | $33.51M | 0.65% |
CORN | -8.31% | $51.34M | 0.2% |
CNYA | -7.11% | $219.11M | 0.6% |
UUP | -6.73% | $327.80M | 0.77% |
ASHR | -6.24% | $2.65B | 0.65% |
SOYB | -6.02% | $25.81M | 0.22% |
UGA | -5.11% | $88.11M | 0.97% |
UNG | -4.82% | $434.44M | 1.06% |
KBA | -3.88% | $198.48M | 0.56% |
DBE | -3.80% | $54.58M | 0.77% |
USCI | -3.38% | $236.09M | 1.07% |
GBIL | -3.07% | $6.31B | 0.12% |
CLOI | -2.73% | $1.02B | 0.4% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
RCKT | 50.54% | $711.22M | -75.04% | 0.00% |
DNLI | 50.37% | $1.97B | -33.88% | 0.00% |
KRYS | 49.65% | $5.19B | +2.40% | 0.00% |
SYRE | 46.99% | $972.25M | -56.39% | 0.00% |
SCVL | 46.46% | $597.57M | -40.57% | 2.45% |
KYMR | 46.18% | $1.78B | -30.57% | 0.00% |
RNA | 46.16% | $3.55B | +11.82% | 0.00% |
ROIV | 45.01% | $7.20B | -3.26% | 0.00% |
CRSP | 45.00% | $2.92B | -50.09% | 0.00% |
DLX | 44.63% | $706.98M | -21.66% | 7.64% |
KN | 44.52% | $1.33B | -5.82% | 0.00% |
RCUS | 44.42% | $830.85M | -57.52% | 0.00% |
CTS | 43.95% | $1.25B | -9.97% | 0.39% |
BEAM | 43.76% | $1.95B | -40.20% | 0.00% |
XNCR | 43.43% | $749.71M | -51.46% | 0.00% |
DIOD | 43.15% | $2.00B | -38.80% | 0.00% |
RYTM | 43.04% | $3.35B | +24.11% | 0.00% |
TBCH | 42.74% | $284.99M | -16.89% | 0.00% |
WD | 42.47% | $2.90B | -13.50% | 3.07% |
RGNX | 42.46% | $358.12M | -66.79% | 0.00% |
SeekingAlpha
The equity portion of the Abrdn Life Sciences Investors Fund fell (gross) but outperformed its benchmark for Q4 2024. Click here to read the full commentary.
Yahoo
REDWOOD CITY, Calif., March 20, 2025--Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases, today announced the appointments of Andrew Galligan and Kristin Myers to its Board of Directors. Mr. Galligan is a proven financial executive who brings over three decades of strategic leadership experience to the Arcellx Board. Ms. Myers, a highly experienced healthcare in
SeekingAlpha
Arcellx's innovative cell therapy platform shows promising potential in treating multiple myeloma, a significant unmet medical need. Read why ACLX is a hold.
Yahoo
We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...
Yahoo
Arcellx (ACLX) delivered earnings and revenue surprises of -38.10% and 44.32%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Yahoo
REDWOOD CITY, Calif., February 27, 2025--Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases, today reported business highlights and financial results for the fourth quarter and year ended December 31, 2024.
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CBOE | -20.21% | $23.69B | +24.42% | 1.08% |
K | -13.48% | $28.48B | +44.57% | 2.75% |
TRVG | -9.60% | $93.53M | +35.76% | 0.00% |
HUSA | -9.02% | $12.08M | -45.38% | 0.00% |
PSQH | -8.47% | $98.27M | -53.36% | 0.00% |
BTCT | -7.69% | $20.20M | +17.54% | 0.00% |
CYCN | -7.64% | $6.78M | -18.57% | 0.00% |
STG | -7.31% | $28.45M | -43.90% | 0.00% |
PCRX | -6.90% | $1.15B | -14.75% | 0.00% |
KO | -6.81% | $308.22B | +18.03% | 2.74% |
LITB | -6.73% | $36.77M | -56.14% | 0.00% |
EXC | -6.58% | $46.52B | +23.77% | 3.35% |
FINV | -6.42% | $1.41B | +89.19% | 2.45% |
CLX | -5.88% | $18.14B | -2.90% | 3.29% |
KDP | -5.84% | $46.43B | +9.57% | 2.59% |
FE | -5.79% | $23.31B | +5.34% | 4.22% |
CATO | -5.35% | $68.39M | -38.79% | 10.15% |
T | -5.09% | $203.00B | +61.60% | 3.91% |
DAO | -4.83% | $238.29M | +83.86% | 0.00% |
HSY | -4.51% | $34.64B | -13.74% | 3.19% |